CopyFind
Lyphidox 10 Injection
medicine 📍 IN

Lyphidox 10 Injection

169,83 ₹

Analogs of Lyphidox 10 Injection

Find cheaper analogs and generic equivalents for Lyphidox 10 Injection.

Ingredients

Princípio ativo: Doxorubicin (Plain)


Visão geral do produto

About Lyphidox 10 Injection

Lyphidox 10 Injection is a medication containing the active ingredient Doxorubicin, classified as Chemotherapy medication. Doxorubicin, sold under the brand name Adriamycin among others, is a chemotherapy medication used to treat cancer. This includes breast cancer, bladder cancer, Kaposi's sarcoma, lymphoma, and acute lymphocytic leukemia. It is often used together with other chemotherapy agents.

Key Benefits & Uses

  • Used for: 1 INDICATIONS AND USAGE Doxorubicin Hydrochloride Injection is an anthracycline topoisomerase inhibitor indicated: • as a component of multi-agent.
  • Use only as directed on the product label or by a healthcare professional.
  • Follow the authorised product information for dosing and duration of use.

Active Ingredient & Action

Doxorubicin, the active ingredient in Lyphidox 10 Injection, belongs to the Chemotherapy medication class. 1 INDICATIONS AND USAGE Doxorubicin Hydrochloride Injection is an anthracycline topoisomerase inhibitor indicated: • as a component of multi-agent adjuvant chemotherapy for treatment of women with axillary lymph node involvement following resection of primary breast cancer ( 1. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Lyphidox 10 Injection. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Lyphidox 10 Injection for extended periods without medical advice.

Find in Pharmacies

Compare local prices and distance for Lyphidox 10 Injection.

Visitor ratings

Help others by rating how useful this product page is.

No ratings yet — be the first.